Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 450 of 994 entries
View as:

AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02675452 Org: User:
Start: 06/13/16 End: 05/27/24 Due: 05/27/25

To Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 386 When Used in Combination With AMG 706, Bevacizumab, Sorafenib, or Sunitinib.

Phase: N/A Priority: Normal
NCT ID: NCT00861419 Org: User:
Start: 12/31/05 End: - Due: -

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01493505 Org: User:
Start: 01/31/12 End: 12/31/16 Due: 12/31/17

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT01568216 Org: User:
Start: 05/31/12 End: 06/30/13 Due: 06/30/14

Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT01389895 Org: User:
Start: 10/31/11 End: 03/31/13 Due: 03/31/14

Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT01854918 Org: User:
Start: 04/23/13 End: 05/31/18 Due: 05/31/19

An Open-Label Study to Assess the Rate of Failure of an Enbrel® (Etanercept) SureClick™ Auto-injector in Subjects With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00346294 Org: User:
Start: 01/31/06 End: 07/31/06 Due: 07/31/07

A Study of Apremilast Use and Effectiveness in Patients With Psoriatic Arthritis in The Netherlands

Phase: N/A Priority: Normal
NCT ID: NCT02875184 Org: User:
Start: 03/06/17 End: 06/30/22 Due: 06/30/23

An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITP

Phase: N/A Priority: Normal
NCT ID: NCT00508820 Org: User:
Start: 02/01/05 End: 03/01/11 Due: 03/01/12

Epoetin Alfa (EPO) in Subjects With Chronic Kidney Disease (CKD)

Phase: N/A Priority: Normal
NCT ID: NCT00156962 Org: User:
Start: 04/30/05 End: 03/31/07 Due: 03/31/08

Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01172938 Org: User:
Start: 06/02/10 End: 10/27/16 Due: 10/27/17

Evolocumab Compared to LDL-C Apheresis in Patients Receiving LDL-C Apheresis Prior to Study Enrollment

Phase: N/A Priority: Normal
NCT ID: NCT02585895 Org: User:
Start: 12/21/15 End: 01/20/17 Due: 01/20/18

Pegfilgrastim PBPC Mobilization Study

Phase: N/A Priority: Normal
NCT ID: NCT00066092 Org: User:
Start: 04/30/03 End: 10/31/04 Due: 10/31/05

Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004

Phase: N/A Priority: Normal
NCT ID: NCT03301857 Org: User:
Start: 11/13/17 End: 07/27/23 Due: 07/27/24

Survey of XGEVA® Presrcibers in Europe to Evaluate Their Knowledge of the Summary of Product Characteristics Pertaining to Osteonecrosis of the Jaw

Phase: N/A Priority: Normal
NCT ID: NCT01998607 Org: User:
Start: 02/04/13 End: 05/15/15 Due: 05/15/16

A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00393822 Org: User:
Start: 08/31/05 End: 03/31/14 Due: 03/31/15

Dose-Escalation Safety Study of HPN-100 to Treat Urea Cycle Disorders

Phase: N/A Priority: Normal
NCT ID: NCT00551200 Org: User:
Start: 10/31/07 End: 12/31/08 Due: 12/31/09

Evaluating Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer Following Treatment With Fluoropyrimidine, Irinotecan, and Oxaliplatin Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00083616 Org: User:
Start: 03/31/04 End: 12/31/08 Due: 12/31/09

Study to Evaluate the Concentration of Denosumab in Seminal Fluid in Healthy Men After a Single Subcutaneous Dose

Phase: N/A Priority: Normal
NCT ID: NCT01869686 Org: User:
Start: 06/30/13 End: 09/30/13 Due: 09/30/14

Pharmacokinetics and Excretion of [¹⁴C]Etelcalcetide (AMG 416) in Patients With End Stage Renal Disease (ESRD) Receiving Dialysis

Phase: N/A Priority: Normal
NCT ID: NCT02054572 Org: User:
Start: 02/07/14 End: 08/15/14 Due: 08/15/15

A Controlled Trial of Erenumab in Migraine Prevention

Phase: N/A Priority: Normal
NCT ID: NCT03812224 Org: User:
Start: 04/12/19 End: 11/25/20 Due: 11/25/21

Efficacy and Safety of Denosumab Compared With Risedronate in Individuals Taking Glucocorticoids

Phase: N/A Priority: Normal
NCT ID: NCT01575873 Org: User:
Start: 03/28/12 End: 06/29/17 Due: 06/29/18

Biomarker and Genetic Predictors of Erenumab Treatment Response

Phase: N/A Priority: Normal
NCT ID: NCT04265755 Org: User:
Start: 10/26/20 End: 01/18/23 Due: 01/18/24

Expanded Access for CC-10004

Phase: N/A Priority: Normal
NCT ID: NCT03740516 Org: User:
Start: - End: - Due: -

A Study of Glyceryl Tri-(4-phenylbutyrate) (GT4P)

Phase: N/A Priority: Normal
NCT ID: NCT00977600 Org: User:
Start: 03/31/05 End: 07/31/05 Due: 07/31/06